Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2021-06-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于2018年限制性股票激励计划首次授予部分第二个解除限售期及预留部分第一个解除限售期解除限售股份上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under a 2018 restricted stock incentive plan. It includes specifics about the number of shares unlocked, the conditions met for unlocking, the dates of board and supervisory meetings approving the unlocking, and the legal opinions related to the unlocking. The document is not a full financial report, audit report, or earnings release, but rather a formal announcement about the lifting of restrictions on shares granted under a stock incentive plan. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share unlocking and related corporate actions, not a report or presentation. The document length is substantial and contains detailed information, but it is not a financial report or management discussion. Therefore, the best classification is Regulatory Filings (RNS).
2021-06-20 Chinese
第二届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company, including approval of stock incentive plan conditions, amendments to the company charter, and the scheduling of a shareholders' meeting. It details voting results and procedural compliance but does not contain financial statements or detailed financial data. It is not an annual or interim report, earnings release, or audit report. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and focused on board decisions rather than financial results or shareholder voting outcomes, so it is not a Declaration of Voting Results (DVA) or Proxy Solicitation (PSI). Therefore, the best classification is MANG with high confidence.
2021-06-14 Chinese
独立董事关于公司第二届董事会第十六次会议审议事项的独立意见
Regulatory Filings Classification · 90% confidence The document is an independent opinion from the independent directors of a company regarding the fulfillment of conditions for lifting restrictions on a stock incentive plan. It discusses compliance with laws and the legitimacy of the stock incentive plan's release conditions. There is no financial data, no report publication, no voting results, no management changes, no earnings or capital updates, and no legal proceedings. The document is a formal opinion related to governance and compliance with stock incentive plans, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2021-06-14 Chinese
大博医疗科技股份有限公司公司章程（2021年6月)
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 大博医疗科技股份有限公司 (Double Medical Technology Inc.). It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, share issuance, shareholder meetings, and other governance matters. It references relevant laws such as the Company Law and Securities Law of China. The content is a comprehensive governance document outlining the internal rules and structure of the company rather than a report of financial results, meeting minutes, or announcements. It is not an Annual Report, Interim Report, or any financial statement. It is not a notice or announcement of a meeting or voting results. It is not a proxy statement or remuneration report. The document fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-06-14 Chinese
关于召开2021年第四次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2021 fourth extraordinary general meeting of shareholders for the company 大博医疗科技股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items (such as amendments to the company charter), registration details, and attachments like proxy forms and voting instructions. There is no financial data or results reported, nor is it a transcript or presentation. The document is clearly an announcement of a shareholders meeting and related voting information, not the results or minutes of the meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this document is a notice to convene the meeting and provide voting instructions rather than the actual voting results or solicitation materials, it is best classified as Proxy Solicitation & Information Statement (PSI). The document length is about 4786 characters, which is consistent with a detailed meeting notice and proxy materials. Hence, the classification is PSI with high confidence.
2021-06-14 Chinese
北京德恒（厦门）律师事务所关于大博医疗科技股份有限公司2018年限制性股票激励计划首次授予部分第二个解除限售期及预留授予部分第一个解除限售期解除限售的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's 2018 restricted stock incentive plan, specifically about the approval, authorization, and conditions for lifting the lock-up periods on certain granted restricted stocks. It contains detailed legal analysis, references to company board and shareholder meetings, audit reports, and compliance with regulatory requirements related to stock incentives. The document is not a financial report, earnings release, or general announcement but a specialized legal opinion on stock incentive plan matters. This type of document fits best under the category of Regulatory Filings (RNS) as it is a legal compliance and regulatory disclosure document that does not fit into other specific categories like Remuneration Information or Board/Management Information. The document length and content confirm it is not a brief announcement or a report publication notice but a substantive legal opinion.
2021-06-14 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.